Table 1.

Characteristics of Persons Included and Persons Not Included in Analysis of Anemia Incidence

Characteristics Included (%)Not Included Because of Total
Anemia Prevalent (%)* Inadequate Follow-up (%) Missing Hemoglobin or CD4 Value (%)
Sex  
 Male  11,254 (85) 4,046 (82)  5,876 (80)  6,130 (84)  27,306 (83) 
 Female  2,061 (15)  899 (18)  1,452 (20) 1,149 (16)  5,561 (17)  
Race  
 White  6,412 (48) 2,007 (41)  2,962 (40)  3,490 (48)  14,871 (45) 
 Black  5,031 (38)  2,348 (47)  3,110 (42) 2,853 (39)  13,342 (41)  
 Hispanic  1,669 (13) 534 (11)  1,135 (15)  843 (12)  4,181 (13) 
 Other†  203 (2)  56 (1)  121 (2)  93 (1) 473 (1)  
Exposure mode  
 Male-male sex  7,656 (57) 2,642 (53)  3,488 (48)  3,581 (49)  17,367 (53) 
 Injecting drug use‡  3,251 (24)  1,238 (25) 1,823 (25)  2,248 (31)  8,560 (26)  
 Heterosexual sex 1,110 (8)  437 (9)  662 (9)  474 (6)  2,683 (8) 
 Other§  1,298 (10)  628 (13)  1,355 (18) 976 (13)  4,257 (13)  
Age, yrs  
 (Median) 34   35   34   32  34   
Total  13,315   4,945  7,328   7,279   32,867  
Characteristics Included (%)Not Included Because of Total
Anemia Prevalent (%)* Inadequate Follow-up (%) Missing Hemoglobin or CD4 Value (%)
Sex  
 Male  11,254 (85) 4,046 (82)  5,876 (80)  6,130 (84)  27,306 (83) 
 Female  2,061 (15)  899 (18)  1,452 (20) 1,149 (16)  5,561 (17)  
Race  
 White  6,412 (48) 2,007 (41)  2,962 (40)  3,490 (48)  14,871 (45) 
 Black  5,031 (38)  2,348 (47)  3,110 (42) 2,853 (39)  13,342 (41)  
 Hispanic  1,669 (13) 534 (11)  1,135 (15)  843 (12)  4,181 (13) 
 Other†  203 (2)  56 (1)  121 (2)  93 (1) 473 (1)  
Exposure mode  
 Male-male sex  7,656 (57) 2,642 (53)  3,488 (48)  3,581 (49)  17,367 (53) 
 Injecting drug use‡  3,251 (24)  1,238 (25) 1,823 (25)  2,248 (31)  8,560 (26)  
 Heterosexual sex 1,110 (8)  437 (9)  662 (9)  474 (6)  2,683 (8) 
 Other§  1,298 (10)  628 (13)  1,355 (18) 976 (13)  4,257 (13)  
Age, yrs  
 (Median) 34   35   34   32  34   
Total  13,315   4,945  7,328   7,279   32,867  

Incidence was examined during the second and third semesters of follow-up.

F0-150

Prevalent anemia was defined as anemia during first semester of follow-up.

F0-151

Asian/Pacific Islander and American Indian/Alaskan Native.

F0-152

Among heterosexuals and men who have sex with men.

F0-153

Includes persons with hemophilia, transfusion and transplant recipients, and persons with no identified risk for HIV infection.

or Create an Account

Close Modal
Close Modal